101. A High Through-Put Screen for Small Molecules Modulating MCM2 Phosphorylation Identifies Ryuvidine as an Inducer of the DNA Damage Response
- Author
-
Sandra Healy, Laura Murillo, Aisling O'Connor, Guan-Nan Wang, Michael D. Rainey, Alessandro Natoni, Corrado Santocanale, Kevin Z. L. Wu, Michael O'Dwyer, Enda O'Connell, Jennifer FitzGerald, and Gemma O'Brien
- Subjects
Phosphorylation ,DNA Damage ,MCM2 ,CDC7 ,lcsh:Medicine ,DNA helicase complex ,Eukaryotic DNA replication ,Cell Cycle Proteins ,Biochemistry ,Cell Signaling ,cdc7 kinase inhibitors ,Nucleic Acids ,topoisomerase-ii ,Molecular Cell Biology ,Drug Discovery ,Medicine and Health Sciences ,Cell Cycle and Cell Division ,s-phase ,Enzyme Inhibitors ,lcsh:Science ,Cellular Stress Responses ,double-strand breaks ,Multidisciplinary ,Protein Kinase Signaling Cascade ,Kinase ,Signaling Cascades ,3. Good health ,Cell biology ,Cell Processes ,Topoisomerase inhibitor ,Research Article ,Signal Transduction ,DNA Replication ,Drug Research and Development ,replication stress ,DNA damage ,medicine.drug_class ,DNA repair ,Biology ,Protein Serine-Threonine Kinases ,ionizing-radiation ,Small Molecule Libraries ,antitumor-activity ,medicine ,Humans ,Pharmacology ,cell-cycle regulation ,DNA synthesis ,Biology and life sciences ,lcsh:R ,DNA replication ,Reproducibility of Results ,Minichromosome Maintenance Complex Component 2 ,DNA ,Cell Biology ,Molecular biology ,High-Throughput Screening Assays ,Enzyme Activation ,lcsh:Q ,protein ,cancer-therapy ,HeLa Cells - Abstract
DNA replication is an essential process for cell division and as such it is a process that is directly targeted by several anticancer drugs. CDC7 plays an essential role in the activation of replication origins and has recently been proposed as a novel target for drug discovery. The MCM DNA helicase complex (MCM2-7) is a key target of the CDC7 kinase, and MCM phosphorylation status at specific sites is a reliable biomarker of CDC7 cellular activity. In this work we describe a cell-based assay that utilizes the "In Cell Western Technique'' (ICW) to identify compounds that affect cellular CDC7 activity. By screening a library of approved drugs and kinase inhibitors we found several compounds that can affect CDC7-dependent phosphorylation of MCM2 in HeLa cells. Among these, Mitoxantrone, a topoisomerase inhibitor, and Ryuvidine, previously described as a CDK4 inhibitor, cause a reduction in phosphorylated MCM2 levels and a sudden blockade of DNA synthesis that is accompanied by an ATM-dependent checkpoint response. This study sheds light on the previously observed cytotoxity of Ryuvidine, strongly suggesting that it is related to its effect of causing DNA damage.
- Published
- 2014